Introducing a new RFP tool

by | Nov 16, 2022 | Newsletter

INTRODUCING A simplified RFP tool Market Check by PCM Dynamically reprice claims Compare multiple contracts See contract vs. market rates Build custom contracts See how it works. INDUSTRY NEWS Health care cost inflation to rise: 8 reasons why. Insulin price cap of $35...

Before an RFP, ask these questions

by | Nov 16, 2022 | Newsletter

NEW BLOG RFP Questions YouShould be Asking When evaluating a PBM contract at renewal or mid-term market check, brokers and plan sponsors should be asking questions. Questions that lead to a thorough understanding of their current PBM contract so they can negotiate...

How is medical pharmacy affecting plan spend?

by | Nov 16, 2022 | Newsletter

NEW BLOG Medical Pharmacy Affects Plan Spend Pharmacy costs get all the press for rising prices; however, brokers and plan sponsors need to consider medical pharmacy if they want a complete picture of plan spend. Read more. INDUSTRY NEWS Biosimilars may be the...

Insulin: How is your plan managing costs?

by | Nov 15, 2022 | Newsletter

NEW BLOG Lowering Diabetes Medication Costs with Alternative Strategies Identifying and covering therapeutic alternatives to high-cost prescription drugs is key to a diabetic-friendly pharmacy program. Plan partners are making this process easier. Read more. INDUSTRY...

Are you ready for 2023?

by | Nov 15, 2022 | Newsletter

Are you ready for 2023? Whether you’re renewing or shopping for pharmacy benefits in2023, PCM has the tools to help contain costs and reduce labor. Read more on our blog: RFP Questions to Ask Managing Drug Rebates Validating Pharmacy Spend INDUSTRY NEWS Drugs...

Are biosimilars included in your formulary?

by | Nov 15, 2022 | Newsletter

NEW BLOG Interchangeable Biosimilars: Plan and Patient Savings Adoption of biosimilars has been slow. The release of an FDA-approved interchangeable biosimilar may provide an added boost in savings. Read more.  Industry News Reevaluate health benefits during open...